645 related articles for article (PubMed ID: 17487367)
1. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
2. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
[TBL] [Abstract][Full Text] [Related]
3. The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells.
Rosenzwajg M; Camus S; Guigon M; Gluckman JC
Exp Hematol; 1998 Jan; 26(1):63-72. PubMed ID: 9430515
[TBL] [Abstract][Full Text] [Related]
4. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
Canque B; Camus S; Yagello M; Gluckman JC
Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
[TBL] [Abstract][Full Text] [Related]
5. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.
Sato K; Nagayama H; Takahashi TA
Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353
[TBL] [Abstract][Full Text] [Related]
6. Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy.
Markowicz S; Niedzielska J; Kruszewski M; Ołdak T; Gajkowska A; Machaj EK; Skurzak H; Pojda Z
Acta Biochim Pol; 2006; 53(1):203-12. PubMed ID: 16404477
[TBL] [Abstract][Full Text] [Related]
7. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha.
Szabolcs P; Moore MA; Young JW
J Immunol; 1995 Jun; 154(11):5851-61. PubMed ID: 7538534
[TBL] [Abstract][Full Text] [Related]
8. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
Siena S; Di Nicola M; Bregni M; Mortarini R; Anichini A; Lombardi L; Ravagnani F; Parmiani G; Gianni AM
Exp Hematol; 1995 Dec; 23(14):1463-71. PubMed ID: 8542932
[TBL] [Abstract][Full Text] [Related]
9. Retroviral-mediated IL-12 gene transduction into human CD34+ cell-derived dendritic cells.
Akiyama Y; Maruyama K; Watanabe M; Yamaguchi K
Int J Oncol; 2002 Sep; 21(3):509-14. PubMed ID: 12168093
[TBL] [Abstract][Full Text] [Related]
10. A serum-free culture model for studying the differentiation of human dendritic cells from adult CD34+ progenitor cells.
Luft T; Pang KC; Thomas E; Bradley CJ; Savoia H; Trapani J; Cebon J
Exp Hematol; 1998 Jun; 26(6):489-500. PubMed ID: 9620282
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
[TBL] [Abstract][Full Text] [Related]
12. Ex-vivo expansion of CFU-GM and BFU-E in unselected PBMC cultures with Flt3L is enhanced by autologous plasma.
Guo M; Miller WM; Papoutsakis ET; Patel S; James C; Goolsby C; Winter JN
Cytotherapy; 1999; 1(3):183-94. PubMed ID: 12881174
[TBL] [Abstract][Full Text] [Related]
13. Stimulatory and inhibitory differentiation of human myeloid dendritic cells.
Chakraborty A; Li L; Chakraborty NG; Mukherji B
Clin Immunol; 2000 Feb; 94(2):88-98. PubMed ID: 10637093
[TBL] [Abstract][Full Text] [Related]
14. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
Zhao W; Xing P; Wei X; Wang T; Yang D; Li M
Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
[TBL] [Abstract][Full Text] [Related]
15. Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells.
Zhou T; Zhang Y; Sun G; Zhang Y; Zhang D; Zhao Y; Chen N
Exp Mol Pathol; 2006 Apr; 80(2):171-6. PubMed ID: 16413535
[TBL] [Abstract][Full Text] [Related]
16. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
Poloni A; Douay L; Giarratana MC; Kobari L; Gorin NC; Olivieri A; Leoni P
Boll Soc Ital Biol Sper; 1997; 73(3-4):55-62. PubMed ID: 9540233
[TBL] [Abstract][Full Text] [Related]
17. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
18. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
[TBL] [Abstract][Full Text] [Related]
19. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
20. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
